Evidence map›Paper›PMID 31263466›Full record

ArticleFrontiers in immunology2019

Longitudinal Analysis of Memory B and T Cell Responses to Dengue Virus in a 5-Year Prospective Cohort Study in Thailand.

Luis A Sánchez-Vargas, Sonia Kounlavouth, Madison L Smith, Kathryn B Anderson, Anon Srikiatkhachorn, Damon W Ellison, Jeffrey R Currier, Timothy P Endy, Anuja Mathew, Alan L Rothman

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. B Cell Dynamics and Transitional B Cells in Long COVID.Current issues in molecular biology · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Responses of CD27Journal of clinical laboratory analysis · 2021
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Luis A Sánchez-VargasInstitute for Immunology and Informatics, University of Rhode Island, Providence, RI, United States.
Sonia KounlavouthInstitute for Immunology and Informatics, University of Rhode Island, Providence, RI, United States.
Madison L SmithInstitute for Immunology and Informatics, University of Rhode Island, Providence, RI, United States.
Kathryn B AndersonDepartment of Medicine, University of Minnesota Medical School, Minneapolis, MN, United States.
Anon SrikiatkhachornInstitute for Immunology and Informatics, University of Rhode Island, Providence, RI, United States.
Damon W EllisonDepartment of Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Jeffrey R CurrierViral Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, MD, United States.
Timothy P EndyDepartment of Microbiology and Immunology, State University of New York-Upstate Medical University, Syracuse, NY, United States.
Anuja MathewInstitute for Immunology and Informatics, University of Rhode Island, Providence, RI, United States.
Alan L RothmanInstitute for Immunology and Informatics, University of Rhode Island, Providence, RI, United States.
Providence College · USUniversity of Rhode Island · USArmed Forces Research Institute of Medical Science · THSUNY Upstate Medical University · USUniversity of Minnesota Medical Center · USWalter Reed Army Institute of Research · US

Funding

VIRAL DETERMINANTS OF SEVERE DENGUE DISEASEP01AI034533 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ROTHMAN, ALAN L · 1994 to 2022
$42.0M
Statistics and Data Management P20GM104317 · NIGMS · UNIVERSITY OF RHODE ISLAND · PI MICHELOW, IAN · 2013 to 2017
$9.8M
NIAID NIH HHS P01 AI034533NIGMS NIH HHS P20 GM104317
6 · The paper itself

Abstract

Prior exposure to dengue virus (DENV) has a profound impact on the outcome of infection, which varies according to the interval between infections. Antibodies secreted by B cells and cytokines secreted by T cells are thought to contribute both to protective immunity against DENV and the pathogenesis of dengue disease. We analyzed peripheral blood mononuclear cells (PBMC) collected from Thai children over a 5-year prospective cohort study to define the dynamics of DENV-specific memory B and T cell responses and the impact of symptomatic or subclinical DENV infections. To measure B cell responses, PBMC were stimulated with IL-2 plus R848 and culture supernatants were tested for DENV-binding antibodies by ELISA. To measure T cell responses, PBMC were stimulated in dual-color ELISPOT assays with overlapping peptide pools of structural and non-structural proteins from the four DENV types. B cell responses were low to one or more DENV types prior to symptomatic infection and increased with reactivity to all four types after infection. Subjects who had a subclinical infection or who did not experience a DENV infection during the study period showed strong memory B cell responses to all four DENV types. T cell responses to DENV peptides demonstrated a cytokine hierarchy of IFN-γ > IL-2 > IFN-γ/IL-2. T cell responses were low or absent prior to secondary infections. The trends in T cell responses to DENV peptides over 3 year post-infection were highly variable, but subjects who had experienced a secondary DENV1 infection showed higher cytokine responses compared to subjects who had experienced a secondary DENV2 or subclinical infection. The longitudinal nature of our study demonstrates persistent memory B cell responses over years and a lasting but variable impact of secondary DENV infection on DENV-specific T cell responses.

Indexed as

Antibodies, ViralAsymptomatic DiseasesB-LymphocytesChildCohort StudiesCytokinesDengueDengue VirusDisease ProgressionFemaleHumansImmunity, CellularImmunologic MemoryLymphocyte ActivationMaleProspective StudiesAntibodies, ViralCytokinesantibodiesB cellscytokinesdengueELISPOTIFN-γIL-2T cells

Identifiers

PMID31263466
PMCPMC6585174
OpenAlexW2949899500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.